International Biotechnology Trust PLC Bei Gene, Ltd. Transaction History

International Biotechnology Trust PLC

$295 Million
Q3 2023

A detailed history of International Biotechnology Trust PLC transactions in Bei Gene, Ltd. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 12,700 shares of BGNE stock, worth $2.42 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

12,700

Previous 8,700 45.98%

Holding current value

$2.42 Million

Previous $1.55 Million 47.26%

% of portfolio

0.78%

Previous 0.48%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$179.87 - $225.13 $719,480 - $900,520	4,000 Added 45.98%	12,700 $2.28 Million
Q2 2023 Aug 08, 2023	SELL	$178.3 - $266.78 $2.5 Million - $3.73 Million	-14,000 Reduced 61.67%	8,700 $1.55 Million
Q1 2023 May 18, 2023	BUY	$215.53 - $274.5 $1.51 Million - $1.92 Million	7,000 Added 44.59%	22,700 $4.89 Million
Q3 2022 Nov 08, 2022	BUY	$131.8 - $202.24 $1.73 Million - $2.66 Million	13,158 Added 517.62%	15,700 $2.12 Million
Q2 2022 Aug 16, 2022	SELL	$121.11 - $216.05 $1.59 Million - $2.84 Million	-13,158 Reduced 83.81%	2,542 $15.7 Million
Q1 2022 May 20, 2022	SELL	$146.52 - $269.56 $630,036 - $1.16 Million	-4,300 Reduced 21.5%	15,700 $2.96 Million
Q4 2021 Feb 15, 2022	BUY	$248.56 - $389.34 $4.97 Million - $7.79 Million	20,000 New	20,000 $5.4 Million
Q1 2020 May 18, 2020	SELL	$121.84 - $173.19 $1.71 Million - $2.42 Million	-14,000 Closed	0 $0
Q4 2019 May 18, 2020	SELL	$115.78 - $208.34 $27.7 Million - $49.9 Million	-239,522 Reduced 94.48%	14,000 $2.32 Million
Q3 2018 Nov 13, 2018	BUY	$152.62 - $189.66 $38.7 Million - $48.1 Million	253,522 New	253,522 $17.4 Million
Q2 2018 Aug 13, 2018	SELL	$152.5 - $216.77 $1.45 Million - $2.06 Million	-9,500 Closed	0 $0
Q4 2017 Mar 02, 2018	BUY	$79.6 - $114.73 $756,200 - $1.09 Million	9,500 New	9,500 $928,000
Q2 2017 Mar 02, 2018	SELL	N/A	-66,041 Closed	0 $0
Q1 2017 Mar 02, 2018	BUY	N/A	66,041	66,041 $2.42 Million

Others Institutions Holding BGNE

# of Institutions

250

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $19.8B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.

Account

International Biotechnology Trust PLC Bei Gene, Ltd. Transaction History